Benda Pharmaceutical, Inc. CFO Featured in Exclusive WallSt.net Interview

HUBEI PROVINCE, CHINA--(MARKET WIRE)--Jul 24, 2007 -- Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTC BB:BPMA.OB - News), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today that Eric Yu, Chief Financial Officer of Benda, will be featured in an exclusive interview with www.WallSt.net on Thursday, July 26 at 10:30 a.m. EST.

MORE ON THIS TOPIC